Century Therapeutics’ Collaboration with Bristol Myers Squibb

Martina Bellini
Tagged:

Troutman Pepper advised Century Therapeutics on the deal.Century Therapeutics (NASDAQ: IPSC) has announced a research collaboration and license agreement with Bristol Myers Squibb (NYSE: BMY) to…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now